“Hydroxychloroquine as Therapeutic Option in COVID-19: Analysis of Suspected Cardiovascular Adverse Drug Events Reported in the VigiBase”, Bangladesh J Med Sci, vol. 20, no. 4, pp. 897–910, Jun. 2021, doi: 10.3329/bjms.v20i4.54150.